Biofarm Ends Jan-Sept 2024 Period With RON73M Net Profit And RON231M Sales

yesterday, 21:40 By Ecaterina Craciun

Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first nine months of 2024 with net profit of RON73.25 million, at an individual level, up 4.7% from the same period of 2023, as per its quarterly financial report published at the Bucharest Stock Exchange on Nov 14.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Biofarm
, earnings